CVS pays over $18m to settle federal and California FCA allegations

The settlement resolves claims from a former CVS pharmacist under federal FCA whistleblower provisions.

The US Department of Justice (DOJ) announced an $18.282m settlement with CVS Pharmacy Inc to resolve allegations that the latter violated the Federal False Claims Act (FCA) and the California False Claims Act. The DOJ alleges the pharmacy chain knowingly filed claims for reimbursement for prescription drugs to California’s Medi-Cal

Free Trial

Register for free to keep reading.

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free Already a member? Sign in